ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more
PRPH is expected to report earnings to -10 cents per share on November 06
Q3'25
Est.
$-0.11
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
Q3'24
Missed
by $0.04
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 696.32K shares outstanding, the current market capitalization sits at 14.81M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRPH showed earnings on August 13, 2025. You can read more about the earnings report here.